GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

The biotech said it would use the cash to “further accelerate” a portfolio led by its GLP-1 receptor agonist MET-097 ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...

BOULDER, CO / ACCESSWIRE / / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists ... primarily because of ...

Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains ... treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...